Related Experiment Video

Updated: Jun 25, 2026

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
12:24

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart

Published on: September 28, 2016

The heart metabolism: pathophysiological aspects in ischaemia and heart failure

K Abozguia1, G Nallur Shivu, I Ahmed

  • 1Department of Cardiovascular Medicine, Medical School, University of Birmingham, Edgbaston, Birmingham, UK. abozguia@gmail.com

Current Pharmaceutical Design
|March 12, 2009
PubMed

Insights

Despite advances, coronary heart disease and heart failure remain serious. This review explores how heart metabolism changes in these conditions and its impact on cardiac energetics, seeking new therapeutic targets.

Area of Science:

  • Cardiology
  • Metabolic research
  • Biochemistry

Background:

  • Coronary heart disease (CHD) and heart failure (HF) significantly increase morbidity and mortality.
  • Current treatments like revascularization and neuro-humoral modification have limitations.
  • New therapeutic strategies are urgently needed to improve patient outcomes.

Purpose of the Study:

  • To review the critical alterations in cardiac metabolism and energetics in CHD and HF.
  • To explore the potential of metabolic modulation as a therapeutic approach for these conditions.
  • To highlight the role of myocardial metabolic disturbances in disease pathophysiology.

Main Methods:

  • Literature review focusing on cardiac metabolism and energetics.
  • Analysis of studies investigating metabolic changes in ischemic heart disease and heart failure.
  • Synthesis of information on the therapeutic potential of metabolic modulation.

Main Results:

  • The myocardium primarily utilizes fatty acids and glucose for Adenosine-5'-triphosphate (ATP) production.
  • Significant shifts in substrate utilization occur during ischemia and heart failure.
  • These metabolic changes profoundly affect cardiac energetics and overall heart function.

Conclusions:

  • Disturbances in cardiac energetics and metabolism are central to CHD and HF.
  • Targeting myocardial metabolism offers a promising avenue for novel therapeutic interventions.
  • Understanding these metabolic alterations is key to developing improved treatments for heart disease.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...